Synthesis of [ 3 H]Org24598 using in‐house prepared [ 3 H]MeI
Journal of Labelled Compounds and Radiopharmaceuticals · 2024
DOI: 10.1002/jlcr.4084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Labelled Compounds and Radiopharmaceuticals, 2024. Verfasst von Michal Kriegelstein und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czechia. Hauptthemen laut MEDLINE: Glycine, Glycine Plasma Membrane Transport Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Czech Academy of Sciences, Akademie Věd České Republiky.
Abstract (Originalsprache)
The synthesis of tritium‐labelled glycine transporter 1 inhibitor Org24598 is reported. Because of the instability of the Org24598 skeleton under hydrogenation conditions, a synthetic approach using an in‐house prepared tritium‐labelled alkylating agent ([ 3 H]MeI, SA = 26.2 Ci/mmol) was employed. Alternative methods of labelling are discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czechia.
ORCID-Profile: Michal Kriegelstein, Aleš Marek
Förderung
- Czech Academy of Sciences
- Akademie Věd České Republiky
Zitieren
APA
Kriegelstein, M., Nováková, G., & Marek, A. (2024). Synthesis of [ 3 H]Org24598 using in‐house prepared [ 3 H]MeI. Journal of Labelled Compounds and Radiopharmaceuticals. https://doi.org/10.1002/jlcr.4084
Vancouver
Kriegelstein M, Nováková G, Marek A. Synthesis of [ 3 H]Org24598 using in‐house prepared [ 3 H]MeI. Journal of Labelled Compounds and Radiopharmaceuticals. 2024. doi:10.1002/jlcr.4084
BibTeX
@article{Kriegelstein2024,
author = {Kriegelstein, Michal and Nováková, Gabriela and Marek, Aleš},
title = {Synthesis of [ 3 H]Org24598 using in‐house prepared [ 3 H]MeI},
journal = {Journal of Labelled Compounds and Radiopharmaceuticals},
year = {2024},
doi = {10.1002/jlcr.4084}
}
EUVIMED